Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H2000

Introduced
2/16/23  
Refer
2/16/23  

Caption

Relative to benzodiazepines and non-benzodiazepine hypnotics

Impact

The bill proposes amendments to the General Laws, particularly Chapter 94C, enhancing the responsibilities of pharmacists and prescribers. One of the notable changes requires pharmacists to include cautionary statements about the risks of long-term benzodiazepine and non-benzodiazepine hypnotic use on labels. Additionally, it mandates the production of informational pamphlets for patients that cover critical information such as the potential for addiction, proper storage, and disposal of these drugs, as well as available addiction support resources. Such measures aim to ensure patients are better informed of the dangers and resources related to these substances.

Summary

House Bill H2000 aims to regulate the prescription and dispensation of benzodiazepines and non-benzodiazepine hypnotics in Massachusetts. This bill addresses growing concerns regarding the misuse, abuse, and potential dependency associated with these medications, which are commonly prescribed for issues such as insomnia and anxiety. By introducing stringent definitions for these substances and establishing new labeling requirements for prescriptions, the bill seeks to enhance patient awareness regarding the risks tied to long-term usage of such medications.

Contention

A key point of contention manifested in discussions surrounding the bill is the establishment of a special commission tasked with studying the protocols for safely discontinuing benzodiazepine use. While proponents argue that the commission is necessary to develop safe practices aimed at minimizing withdrawal symptoms, some critics have raised concerns about the effectiveness and feasibility of implementing state-level regulations for discontinuation procedures. The requirement that patients have to provide written informed consent before receiving prescriptions for these drugs has also been met with mixed reactions, as it may introduce additional barriers to access for patients who need these medications for legitimate medical reasons.

Companion Bills

MA S1236

Similar To Relative to benzodiazepines and non-benzodiazepine hypnotics

Previously Filed As

MA H2223

Relative to benzodiazepines and non-benzodiazepine hypnotics

MA S1236

Relative to benzodiazepines and non-benzodiazepine hypnotics

MA A628

Establishes certain protocols for prescribing and dispensing benzodiazepine.

MA A658

Establishes certain protocols for prescribing and dispensing benzodiazepine.

MA H2414

Relative to patient assessment and notification prior to prescribing certain medications

MA H2164

Relative to patient assessment and notification prior to prescribing certain medications

MA H5143

Relative to treatments and coverage for substance use disorder and recovery coach licensure

MA S2921

Site Information & Links

MA H4743

Relative to treatments and coverage for substance use disorder and recovery coach licensure

MA H4758

Relative to treatments and coverage for substance use disorder and recovery coach licensure

Similar Bills

NJ A658

Establishes certain protocols for prescribing and dispensing benzodiazepine.

NJ A628

Establishes certain protocols for prescribing and dispensing benzodiazepine.

MA H2223

Relative to benzodiazepines and non-benzodiazepine hypnotics

MA S1236

Relative to benzodiazepines and non-benzodiazepine hypnotics

WV SB703

Relating to controlled substances schedule

WV SB179

Relating to controlled substances schedule

WV SB546

Adding and removing certain compounds from controlled substance list

CA AB714

Opioid prescription drugs: prescribers.